Impact of surgical delay on long-term cancer control for clinically localized prostate cancer

Journal of Urology

Volumn 172, Issue 5 I, 2004, Pages 1835-1839

  Khan, Masood A ^a   Mangold, Leslie A ^a   Epstein, Jonathan I ^a   Boitnott, John K ^a   Walsh, Patrick C ^a   Partin, Alan W ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Prostate; Prostatectomy; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RADICAL RETROPUBIC PROSTATECTOMY; RECURRENCE RISK; SCORING SYSTEM; SURVIVAL RATE; TREATMENT INDICATION;

EID: 5444254511     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000140277.08623.13     Document Type: Article

References (10)

1. Catalona, W. J., Smith, D. S., Ratliff, T. L. and Basler, J. W.: Detection of organ-confined prostate cancer is increased through prostate-specific antigen based screening. JAMA, 270: 948, 1993
2. Gann, P. H., Hennekens, C. H. and Stampfer, M. J.: A prospective evaluation of plasma prostate-specific antigen for detection of prostate cancer. JAMA, 273: 289, 1995
3. Carter, H. B. and Pearson, J. D.: PSA and the natural course of prostate cancer. In: Recent Advances in Prostate Cancer and BPH. Edited by F. H. Schroeder. New York: Parthenon, pp. 187-193, 1997
4. Walsh, P. C.: Anatomic radical retropubic prostatectomy. In: Campbell's Urology, 8th ed. Edited by P. C. Walsh, A. B. Retik, E. D. Vaughan, Jr. and A. J. Wein. Philadelphia: W. B. Saunders Co., vol. 4, sect. XI, chapt. 90, pp. 3107-3129, 2002
5. Nam, R. K., Jewett, M. A., Krahn, M. D., Robinette, M. A., Tsihlias, J., Toi, A. et al: Delay in surgical therapy for clinically localized prostate cancer and biochemical recurrence after radical prostatectomy. Can J Urol, 10: 1891, 2003
6. Beahrs, O. H., Henson, D. E. and Hutter, R. V. P.: American Joint Committee on Cancer Staging Manual, 5th ed. Philadelphia: J. B. Lippincott Co., 1992
7. Epstein, J. I., Walsh, P. C. and Ballantine Carter, H.: Dedifferentiation of prostate cancer grade with time in men followed expectantly for stage T1c disease. J Urol, 166: 1688, 2001
8. Catalona, W. J., Smith, D. S. and Ornstein, D. K.: Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements. JAMA, 277: 1452, 1997
9. Rietbergen, J. B. W., Hoedemaeker, R. F., Boeken Kruger, A. E., Kirkels, W. J. and Schroder, F. H.: The changing pattern of prostate cancer at the time of diagnosis: characteristics of screen detected prostate cancer in a population based screening study. J Urol, 161: 1192, 1999
10. Khan, M. A., Han, M., Partin, A. W., Epstein, J. I. and Walsh, P. C.: Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003. Urology, 62: 86, 2003